The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Published Online:https://doi.org/10.1176/ajp.105.11.843

A control group of 757 personnel and a test group of 1,875 neuropsychiatric patients were surveyed for symptoms and signs of allergy. In order to validate the material, the survey was made when an allergen (ragweed pollen) was a common environmental circumstance for both groups in the same geographical location. The survey, by history, among the control group revealed an incidence of major allergic symptoms of 21% and an incidence by physical signs of 13%. This group represented a cross section of the population for the area in which the study was made.

Among the test group of patients, the majority of whom were psychotic, the incidence of symptoms by history was 5.7%, and the incidence of positive physical signs, 2.9%. The incidence of physical signs among schizophrenic patients was 2.9% and among manic-depressive psychotics, 1.4%. Among epileptics, it was 13% and among organic psychoses, 3.0%. The survey is considered valid since it was made under controlled conditions, the findings were objective, and the survey is open to repetition.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.